Back

Initial assessment of the clinical impact and confirmation of the diagnostic ability of the 18F-FDG-PET/CTA prosthetic valve endocarditis.

13 May 2019 (10:30 - 10:36)
Organised by:
Congress Presentation Part of: Moderated Posters 3 Positron Emission Tomography (PET) ESC Premium Access ICNC 2019

About the speaker

Photo
Doctor Maria Nazarena Pizzi

University Hospital Vall d'Hebron, Barcelona (Spain)

8 More presentations in this session

Presentation thumbnail
CT TAVR assessment in the United Kingdom: insights from a national BSCI/BSCCT survey
Doctor M. Williams (Edinburgh, GB)
Abstract Slides
Presentation thumbnail
Clinical utility of CT angiography over and above TAVI procedural planning
Doctor K. Patel (London, GB)
Abstract Slides
Presentation thumbnail
Aortic valve calcium score in patients undergoing TAVI: would 3mensio software be an alternative to the classic Agatston score?
Doctor J. Rigueira (Lisbon, PT)
Abstract
Presentation thumbnail
Early effect of transcatheter aortic valve implantation on cardiac sympathetic nervous function assessed by 123i-metaiodobenzylguanidine scintigraphy in patients with severe aortic stenosis
Doctor Y. Kadoya (Ottawa, CA)
Abstract
Presentation thumbnail
Assessment of osteoblastic activity with 18F-sodium fluoride PET in aortic bioprosthesis structural valve dysfunction : first results of a monocentric observational pilot study.
Doctor A. Pallardy (Nantes, FR)
Abstract Slides

Access the full session

Session thumbnail
Moderated Posters 3

The Event

Event poster

ICNC 2019

13 May 2019 10:30 CET
You may be interested in
thumbnail
Congress Presentation
Total-body PET: what is it and what might it offer?
thumbnail
Congress Presentation
Total-body positron emission tomography/CT in cardiology: are we ready for it? - discussion
thumbnail
Congress Presentation
What comes next in nuclear cardiology?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources